MoneyWorks4Me

J.B. Chemicals & Pharmaceuticals informs about disclosure

16 Jan 2025 Evaluate
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), J.B. Chemicals & Pharmaceuticals has informed that the Company has received Order from Deputy Commissioner of CGST, Gujarat. The relevant information in the format prescribed by SEBI vide its circular no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed. Nature and details of the action(s) taken, initiated or order(s) passed: Demand of Rs. 80.86 lakhs in respect of mismatch in input tax credit availed during FY 2020-21.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..